|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12TH STREET, SW |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 72031-12
|
||||||||
|
6. House ID# 359130000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lucia DiVenere, Director, Ob-Gyns for Women's Health |
Date | 10/17/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R.2638, Continuing resolution (Division A); S. 3604, Making Emergency Supplemental Appropriations for the Fiscal Year Ending September 30, 2008, and for Other Purposes (Section 3001, Temporary Increase of FMAP; Chapter 7, National Institutes of Health); S. 3288, Department of State, Foreign Operations and Related Programs Appropriations Act, 2009 (Title III, child health and family planning); H.R. 2642, Supplemental Appropriations Act, 2008 (Chapter 4, National Institutes of Health)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Tara |
Straw |
|
|
|
Josef |
Weissfeld |
|
|
|
Nevena |
Minor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.Con.Res. 400/S.Res.638, Health Care for Women, Health Care for All. Regulatory comments on FDA's proposed pregnancy and lactation label rule. FDA Advisory Committee nomination letters. S. 1375, MOTHER's Act. S. 3297, Advancing America's Priorities Act, in particular Subtitle D (postpartum depression), Subtitle F (Prenatally and Postnatally Diagnosed Conditions Act). Health information technology (general). S.1810, the Prenatally and Postnatally Diagnosed Condition Act.
H.R. 1014/S. 573, Heart for Women Act. Comments to the Federal Trade Commission final rule on Identity Theft Red Flags; 16 CFR Part 681. Comments to the Drug Enforcement Administration proposed rule on the Electronic Prescriptions for Controlled Substances, 21 CFR Parts 1300, 1304, et al. (June 27, 2008). Docket No. DEA218. Comments to HHS regarding draft language relating to provider conscience. Comments regarding Ensuring that Department of Health and Human Services Funds Do Not Support Coercive or Discriminatory Policies or Practices in Violation of Federal Law, RIN 0991-AB48, 73 Fed. Reg. 50274.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Federal Trade Commission (FTC), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
Divenere |
|
|
|
Tara |
Straw |
|
|
|
Josef |
Weissfeld |
|
|
|
Nevena |
Minor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R.6331, Medicare Improvements for Patients and Providers Act, in particular, sections 101 (coverage of preventive services), 131 (payment and quality reporting), 132 (electronic prescribing), 135 (imaging). S.3656, Preserving Access to Healthcare, Section 5, Extending California's family planning waiver. Letter regarding Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY2009; Proposed Rule; CMS-1403-P; Sections relating to independent
diagnostic testing facilities, Physician Quality Reporting Initiative, Healthcare-Aquired Conditions, Budget Neutrality Adjustment, Physician Enrollment, and E-prescribing. Discussion with CMS regarding Physician Compare website proposal.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Tara |
Straw |
|
|
|
Josef |
Weissfeld |
|
|
|
Nevena |
Minor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
H.R.1328, Indian Health Care Improvement Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Tara |
Straw |
|
|
|
Joseph |
Weissfeld |
|
|
|
Nevena |
Minor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Letter to Sec Spellings regarding proposed rule on the Federal Perkins Loan Program, the Federal Family Education Loan Program, and the William D. Ford Federal Direct Loan Program, 34 CFR Parts 674, 682, and 685.
17. House(s) of Congress and Federal agencies Check if None
Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Tara |
Straw |
|
|
|
Josef |
Weissfeld |
|
|
|
Nevena |
Minor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |